CT Angiogram is Strongly Recommended for Spontaneous ICH in Patients Under 45
In a patient under 45 years presenting with spontaneous intracerebral hemorrhage, acute CT angiography (CTA) with consideration of venography is recommended as the next imaging study to exclude macrovascular causes or cerebral venous thrombosis. This is a Class 1, Level B-NR recommendation from the 2022 AHA/ASA guidelines 1.
Why CTA is Critical in Young Patients
The rationale is compelling: among individuals under 45 with spontaneous ICH, an underlying macrovascular cause (arteriovenous malformations, aneurysm, dural arteriovenous fistula, cavernoma, or cerebral venous thrombosis) is present in 1 of 4 to 1 of 7 patients 1. Missing these lesions has profound implications for mortality and morbidity—these are potentially treatable causes that fundamentally alter management and prognosis.
Diagnostic Performance
CTA demonstrates >90% sensitivity and specificity for detecting intracranial vascular malformations compared to the gold standard digital subtraction angiography (DSA) 1. Research confirms this with pooled diagnostic accuracy of 97.2% across multiple studies 2.
Age-Based Algorithm for CTA
The decision to perform CTA depends on age, hemorrhage location, and hypertension history:
Definite Indications (Class 1 Recommendation):
- Deep or posterior fossa ICH + age <45 years (regardless of hypertension status) 1
- Lobar ICH + age <70 years 1
- Deep/posterior fossa ICH + age 45-70 years WITHOUT hypertension history 1
- Isolated intraventricular hemorrhage (any age) 1
CTA Can Be Omitted:
Patients >65 years with hypertension history and deep hemorrhage (basal ganglia, thalamus, or cerebellum) have essentially 0% yield for finding structural vascular lesions 3. In these cases, CTA adds cost and contrast exposure without diagnostic benefit.
Timing Matters
CTA should be performed acutely—ideally within the first 24 hours 1. The median interval in the DIAGRAM study was 1 day from initial CT 1. Early identification of vascular malformations directly influences acute treatment decisions, surgical planning, and prevents catastrophic rebleeding.
What to Include with CTA
Add CT venography when:
- Clinical factors suggest possible cerebral venous thrombosis
- Hemorrhage location is atypical (e.g., parasagittal, near venous sinuses)
- Patient has prothrombotic risk factors 1
If CTA is Negative
When CTA shows no vascular abnormality in high-risk patients (young, non-hypertensive), MRI with MRA is reasonable to identify non-macrovascular causes like cerebral amyloid angiopathy, cavernous malformations, or underlying malignancy 1. Blood-sensitive sequences (T2*-weighted, susceptibility-weighted imaging) are essential to detect microbleeds and cortical superficial siderosis.
For patients under 45 with deep/posterior fossa ICH and negative CTA/MRI, catheter DSA is reasonable (Class 2a recommendation) as it has higher diagnostic yield—identifying lesions in an additional 13% of cases 1.
Common Pitfalls to Avoid
Don't skip CTA based solely on "typical hypertensive hemorrhage" appearance in young patients—the diagnostic yield remains 17% even in seemingly straightforward cases 1
Female sex increases likelihood of vascular lesions—don't be falsely reassured by demographics 1
Absence of small vessel disease on imaging increases probability of finding a macrovascular cause—this should prompt CTA, not defer it 1
Don't delay CTA for "clinical stability"—vascular lesions can rebleed catastrophically, and early identification changes management
The evidence is unequivocal: for spontaneous ICH in patients under 45, CTA is not optional—it's essential standard of care that directly impacts survival and long-term outcomes by identifying treatable causes.